Caprock Group, Inc. Abbott Laboratories Transaction History

Caprock Group, Inc.

$2.71 Billion
Q3 2024

A detailed history of Caprock Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Caprock Group, Inc. holds 48,075 shares of ABT stock, worth $5.67 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

48,075

Previous 44,484 8.07%

Holding current value

$5.67 Million

Previous $4.62 Million 18.59%

% of portfolio

0.2%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$100.07 - $118.13 $359,351 - $424,204	3,591 Added 8.07%	48,075 $5.48 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $1.42 Million - $1.59 Million	14,107 Added 46.44%	44,484 $4.62 Million
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $114,338 - $126,282	1,044 Added 3.56%	30,377 $3.45 Million
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $1,352 - $1,656	15 Added 0.05%	29,333 $3.23 Million
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $169,279 - $203,106	1,772 Added 6.43%	29,318 $2.84 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $360,792 - $401,998	3,580 Added 14.94%	27,546 $3 Million
Q1 2023 Apr 26, 2023	BUY	$96.86 - $114.01 $178,512 - $210,120	1,843 Added 8.33%	23,966 $2.43 Million
Q4 2022 Jan 23, 2023	BUY	$95.06 - $111.52 $119,870 - $140,626	1,261 Added 6.04%	22,123 $0
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $37,542 - $43,467	388 Added 1.9%	20,862 $2.02 Million
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $170,661 - $206,274	1,672 Added 8.89%	20,474 $2.23 Million
Q1 2022 Apr 12, 2022	BUY	$114.02 - $139.04 $237,617 - $289,759	2,084 Added 12.47%	18,802 $2.23 Million
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $308,118 - $377,273	-2,667 Reduced 13.76%	16,718 $2.35 Million
Q3 2021 Oct 07, 2021	BUY	$116.66 - $129.06 $291,766 - $322,779	2,501 Added 14.81%	19,385 $2.29 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $209,358 - $246,444	-1,979 Reduced 10.49%	16,884 $1.96 Million
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $451,903 - $532,410	-4,152 Reduced 18.04%	18,863 $2.26 Million
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $72,660 - $79,178	692 Added 3.1%	23,015 $2.52 Million
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $624,709 - $758,663	-6,817 Reduced 23.39%	22,323 $2.43 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $121,440 - $155,428	1,586 Added 5.76%	29,140 $2.66 Million
Q1 2020 Apr 28, 2020	BUY	$62.82 - $91.86 $742,532 - $1.09 Million	11,820 Added 75.12%	27,554 $2.17 Million
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $16,644 - $18,528	212 Added 1.37%	15,734 $1.37 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $14,322 - $15,529	-175 Reduced 1.11%	15,522 $1.3 Million
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $2,040 - $2,380	28 Added 0.18%	15,697 $1.32 Million
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $13,641 - $16,492	206 Added 1.33%	15,669 $1.25 Million
Q4 2018 Jan 29, 2019	BUY	$65.56 - $74.27 $90,013 - $101,972	1,373 Added 9.74%	15,463 $1.12 Million
Q3 2018 Oct 17, 2018	SELL	$60.81 - $73.36 $63,972 - $77,174	-1,052 Reduced 6.95%	14,090 $1.03 Million
Q2 2018 Jul 23, 2018	SELL	$57.57 - $63.54 $14,047 - $15,503	-244 Reduced 1.59%	15,142 $924,000
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $151,084 - $170,819	-2,685 Reduced 14.86%	15,386 $922,000
Q4 2017 Jan 17, 2018	SELL	$53.68 - $57.47 $773,314 - $827,912	-14,406 Reduced 44.36%	18,071 $1.07 Million
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $1.56 Million - $1.74 Million	32,477	32,477 $1.73 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Abbott Laboratories Transaction History